RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 40 filers reported holding RENEO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $0 | -100.0% | 118 | -81.5% | 0.00% | – |
| Q1 2024 | $1 | – | 637 | +188.2% | 0.00% | – |
| Q4 2023 | $0 | -100.0% | 221 | -6.8% | 0.00% | – |
| Q3 2023 | $2 | -97.8% | 237 | -98.3% | 0.00% | – |
| Q2 2023 | $90 | – | 13,700 | +20657.6% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 66 | -98.4% | 0.00% | – |
| Q1 2022 | $12,000 | -66.7% | 4,210 | 0.0% | 0.00% | – |
| Q4 2021 | $36,000 | +16.1% | 4,210 | 0.0% | 0.00% | – |
| Q3 2021 | $31,000 | -74.4% | 4,210 | -67.6% | 0.00% | – |
| Q2 2021 | $121,000 | – | 12,980 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,534,220 | $4,054,752 | 14.95% |
| BML Capital Management, LLC | 1,314,229 | $2,102,766 | 1.59% |
| Octagon Capital Advisors LP | 2,250,000 | $3,600,000 | 0.58% |
| NEA Management Company, LLC | 4,785,494 | $7,656,790 | 0.51% |
| TANG CAPITAL MANAGEMENT LLC | 3,330,000 | $5,328,000 | 0.49% |
| Aisling Capital Management LP | 886,075 | $1,417,720 | 0.42% |
| Carlyle Group Inc. | 2,698,957 | $4,318,331 | 0.21% |
| Ikarian Capital, LLC | 1,082,600 | $1,732,160 | 0.16% |
| FIFTH LANE CAPITAL, LP | 40,000 | $64,000 | 0.08% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,121,704 | $1,794,726 | 0.07% |